Related Experiment Videos
Treatment of severe bacteroides infections with parenteral clindamycin
Canadian Medical Association Journal
|December 23, 1972
Abstract:
Clindamycin, by intravenous or intramuscular administration, was used in the treatment of 18 patients seriously ill with infections due to bacteroides organisms. In 17 cases there was a rapid favourable clinical response to treatment. No serious toxic effects were observed. This study appears to confirm previous in vitro evidence that clindamycin is presently the antibiotic of choice for such infections.
Insights
Clindamycin effectively treated serious bacteroides infections in 17 of 18 patients. This antibiotic showed a rapid response and no significant toxicity, confirming its role as a primary treatment option.
Area of Science:
- Infectious Diseases
- Pharmacology
- Microbiology
Background:
- Bacteroides organisms are a common cause of serious infections.
- Effective antibiotic treatment is crucial for managing these severe conditions.
Purpose of the Study:
- To evaluate the efficacy and safety of clindamycin in treating serious infections caused by bacteroides organisms.
- To confirm clindamycin's suitability as a first-line antibiotic for bacteroides infections.
Main Methods:
- Intravenous and intramuscular administration of clindamycin.
- Treatment of 18 patients with severe bacteroides infections.
Main Results:
- A rapid and favorable clinical response was observed in 17 out of 18 patients.
- No serious adverse toxic effects were reported during the treatment period.
Conclusions:
- Clindamycin demonstrates high efficacy in treating severe bacteroides infections.
- The findings support clindamycin as the antibiotic of choice for these infections, consistent with in vitro data.